GlassScriptPhysician profile
Jeffrey W Cameron
NPI 1225033889
$10,192.18
in general payments reported to CMS, 2019-2025
43 companies · $682 in 2025
The $682 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,839 · 2020: $443 · 2021: $1,050 · 2022: $2,959 · 2023: $1,135 · 2024: $1,084 · 2025: $682.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,901.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,900.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,873.91 | 2021-2025 | Endurant Iis, Hawkone, Turbohawk |
| Silk Road Medical, INC. | $1,354.81 | 2019-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Endologix LLC | $960.64 | 2022-2024 | Endocross Device, Torus Stent Graft System, Alto Abdominal Stent Graft System |
| Bard Peripheral Vascular, INC. | $833.74 | 2019 | |
| Medtronic Vascular, INC. | $821.97 | 2019-2020 | |
| Abbott Laboratories | $473.22 | 2020-2022 | |
| W. L. Gore & Associates, INC. | $339.84 | 2019-2024 | Gore Viabahn Vbx Balloon Expandable Endo, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Lemaitre Vascular, INC. | $334.21 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $317.08 | 2019-2022 | |
| Penumbra, INC. | $199.22 | 2019-2025 | Indigo System |
| Shockwave Medical, INC | $195.57 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $146.84 | 2024 | (Bh4) Igt Devices Undivided |
| Aroa Biosurgery Incorporated | $143.79 | 2025 | |
| Zimmer Biomet Holdings, INC. | $120.65 | 2019 | |
| Balt USA, LLC | $107.53 | 2022 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mozarc Medical US LLC | $79.26 | 2023 | Palindrome |
| Teleflex LLC | $77.84 | 2023-2025 | Quikclot, Manta |
| Smith+Nephew, INC. | $76.94 | 2022-2025 | Pico 14, Collagenase Santyl |
| Tela Bio, INC. | $67.83 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Cardiva Medical, INC. | $57.60 | 2022 | |
| Intuitive Surgical, INC. | $47.65 | 2019 | |
| Polynovo North America LLC | $46.15 | 2024-2025 | Novosorb Btm |
| Medistim USA, INC. | $43.80 | 2022 | |
| Medline Industries LP | $37.85 | 2019 | |
| Organogenesis INC. | $33.00 | 2020-2022 | |
| Stryker Corporation | $31.86 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Angiodynamics, INC. | $30.92 | 2021 | |
| Abbvie INC. | $30.03 | 2021-2022 | |
| Cook Medical LLC | $29.61 | 2019-2025 | Icast Covered Stent System, 6mmx22mmx120cm |
| Olympus America INC. | $29.23 | 2019 | |
| Bolton Medical INC | $28.93 | 2019 | |
| Merck Sharp & Dohme LLC | $25.75 | 2019-2021 | |
| Acell, INC. | $25.43 | 2020 | |
| Davol INC. | $22.72 | 2020 | |
| Integra Lifesciences Corporation | $22.15 | 2022 | |
| Tactile Systems Technology INC | $19.67 | 2023 | Flexitouch Plus, Entre Plus |
| Molnlycke Health Care US, LLC | $17.95 | 2021 | |
| Janssen Biotech, INC. | $16.75 | 2025 | Tremfya |
| Avinger INC. | $16.66 | 2019 | |
| Sanara Medtech INC. | $14.07 | 2023 | Celleraterx |
| Solventum Corporation | $14.01 | 2025 | V.A.C. Veraflo, V.A.C.Ulta, Prevena |
| Acera Surgical, INC. | $12.78 | 2019 | |
| Venturemed Group, INC. | $12.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Cameron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.